Correlation Between Collegium Pharmaceutical and Phibro Animal

Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and Phibro Animal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and Phibro Animal into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Collegium Pharmaceutical and Phibro Animal Health, you can compare the effects of market volatilities on Collegium Pharmaceutical and Phibro Animal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of Phibro Animal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and Phibro Animal.

Diversification Opportunities for Collegium Pharmaceutical and Phibro Animal

0.24

Correlation Coefficient

Collegium Pharmaceutical  Phibro Animal

Modest diversification

The 3 months correlation between Collegium and Phibro is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and Phibro Animal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phibro Animal Health and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with Phibro Animal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phibro Animal Health has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and Phibro Animal go up and down completely randomly.

Pair Corralation between Collegium Pharmaceutical and Phibro Animal

Given the investment horizon of 90 days Collegium Pharmaceutical is expected to generate 3.8 times less return on investment than Phibro Animal. But when comparing it to its historical volatility, Collegium Pharmaceutical is 2.04 times less risky than Phibro Animal. It trades about 0.09 of its potential returns per unit of risk. Phibro Animal Health is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  1,058  in Phibro Animal Health on February 7, 2024 and sell it today you would earn a total of  587.00  from holding Phibro Animal Health or generate 55.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Collegium Pharmaceutical  vs.  Phibro Animal Health

Collegium Pharmaceutical

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Collegium Pharmaceutical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak essential indicators, Collegium Pharmaceutical disclosed solid returns over the last few months and may actually be approaching a breakup point.

Phibro Animal Health

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Phibro Animal Health are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical indicators, Phibro Animal exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Collegium Pharmaceutical and Phibro Animal

The main advantage of trading using opposite Collegium Pharmaceutical and Phibro Animal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, Phibro Animal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phibro Animal will offset losses from the drop in Phibro Animal's long position.

The idea behind Collegium Pharmaceutical and Phibro Animal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.